NSC 23925 blocks the action of P-glycoprotein, a key player in drug transport and resistance, thereby enhancing the effectiveness and bioavailability of therapeutic drugs.
Molecular Weight
421.36
Molecular Formula
C22H26Cl2N2O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
NSC 23925 is a P-gp inhibitor used to study multidrug resistance in cancer therapy.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
